Israel’s Sanoculis has received the CE Mark for its MINT (Minimally Invasive Nasal Trabeculostomy) product for the treatment of adult patients undergoing glaucoma angle surgery. (See MINT and MIMS on Sanoculis website)
European approval for glaucoma treatment
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.